Comparative analysis of connective tissue disease-associated interstitial lung disease and idiopathic pulmonary fibrosis from a tertiary care centre in Pakistan

Comparative analysis of connective tissue disease-associated interstitial lung disease and idiopathic pulmonary fibrosis from a tertiary care centre in Pakistan

Objectives: The burden of interstitial lung disease (ILD) is rising globally. This study aimed to describe and compare characteristics of Connective Tissue Disease-associated ILD with Idiopathic Pulmonary Fibrosis, the two most commonly observed ILDs among outpatients at a tertiary care hospital in...

Full description

Bibliographic Details
Main Authors:	Ali Bin Sarwar Zubairi, Huzaifa Ahmad, Maryam Hassan, Faraz Siddiqui, Nousheen Iqbal, Mehmood Riaz, Muhammad Irfan
Format:	Article
Language:	English
Published:	Pakistan Medical Association 2021-07-01
Series:	Journal of the Pakistan Medical Association
Online Access:	https://www.ojs.jpma.org.pk/index.php/public_html/article/view/526

Similar Items

Idiopathic pulmonary fibrosis in a Swiss interstitial lung disease reference centre
by: Sabina A. Guler, et al.
Published: (2018-01-01)

Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
by: Francesco Amati, et al.
Published: (2022-01-01)

Is pirfenidone ready for use in non-idiopathic pulmonary fibrosis interstitial lung diseases?
by: Sahajal Dhooria, et al.
Published: (2015-01-01)

Validation of the King’s Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis
by: Thomas Skovhus Prior, et al.
Published: (2019-12-01)

Beyond idiopathic pulmonary fibrosis: the world of progressive-fibrosing interstitial lung disease
by: Sergio Harari
Published: (2018-12-01)

Cancer and how the patients see it; prevalence and perception of risk factors: a cross-sectional survey from a tertiary care centre of Karachi, Pakistan
by: Saira Saeed, et al.
Published: (2019-04-01)

Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
by: Paola Faverio, et al.
Published: (2021-09-01)

Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases
by: Verónica Pulito-Cueto, et al.
Published: (2023-01-01)

Serum Biomarkers in Differential Diagnosis of Idiopathic Pulmonary Fibrosis and Connective Tissue Disease-Associated Interstitial Lung Disease
by: Eva Cabrera Cesar, et al.
Published: (2021-07-01)

Underlying Conditions and Clinical Spectrum of Chronic Pulmonary Aspergillosis (CPA): An Experience from a Tertiary Care Hospital in Karachi, Pakistan
by: Nousheen Iqbal, et al.
Published: (2020-03-01)

Role of Telomere Length in Survival of Patients with Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
by: Sofía Tesolato, et al.
Published: (2023-12-01)

Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis
by: Boyang Zheng, et al.
Published: (2023-04-01)

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis
by: Sang Hoon Lee, M.D., et al.
Published: (2019-04-01)

Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis
by: Noriyuki Enomoto, et al.
Published: (2020-06-01)

Early clinical experiences with nintedanib in three UK tertiary interstitial lung disease centres
by: Hannah Toellner, et al.
Published: (2017-11-01)

Differentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging
by: Jonathan H. Chung, et al.
Published: (2021-06-01)

Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis
by: Reoto Takei, et al.
Published: (2023-06-01)

Pharmacological treatment of idiopathic pulmonary fibrosis and fibrosing interstitial lung diseases: current trends and future directions
by: Won-Il Choi
Published: (2021-03-01)

Sarcoid Uveitis: An Experience from a Tertiary Care Hospital in Pakistan.
by: Mohammad Ishaq, et al.
Published: (2024-02-01)

Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review
by: Francesco Amati, et al.
Published: (2023-04-01)

The application of metabolomics toward idiopathic pulmonary fibrosis and potential metabolomic value of diverse samples in interstitial lung diseases
by: Mingtao Liu, et al.
Published: (2023-09-01)

Risk factors of idiopathic pulmonary fibrosis in Pakistani population: a matched case-control study
by: Ali Bin Sarwar Zubairi, et al.
Published: (2023-08-01)

Sarcoidosis: an experience from a tertiary care center in Karachi Pakistan
by: Mustafa Ali Khan, et al.
Published: (2022-04-01)

Granulomatosis with polyangiitis: a 17 year experience from a tertiary care hospital in Pakistan
by: Omar Irfan, et al.
Published: (2018-05-01)

The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study
by: Paolo Cameli, et al.
Published: (2022-08-01)

Lung Microbiota in Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis, and Unclassified Interstitial Lung Diseases: A Preliminary Pilot Study
by: Milena Adina Man, et al.
Published: (2023-10-01)

Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease – analysis of institutional and population data
by: Joo Heung Yoon, et al.
Published: (2018-10-01)

The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias
by: G. Raghu, et al.
Published: (2008-12-01)

Acute exacerbation of idiopathic pulmonary fibrosis: usual interstitial pneumonitis vs. possible usual interstitial pneumonitis pattern
by: Meng-Shu Cao, et al.
Published: (2019-09-01)

Electronic cigarettes use and perception amongst medical students: a cross sectional survey from Sindh, Pakistan
by: Nousheen Iqbal, et al.
Published: (2018-03-01)

Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies
by: Hajime Yoshifuji
Published: (2016-04-01)

Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies
by: Hajime Yoshifuji
Published: (2015-01-01)

Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies
by: Hidenaga Kawasumi, et al.
Published: (2015-01-01)

Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias
by: Daniel Traila, et al.
Published: (2018-01-01)

HOSPITALIZATION DUE TO COMIOGENIC DISEASES IN TERTIARY CARE HOSPITAL PESHAWAR PAKISTAN
by: Majid Khan, et al.
Published: (2023-01-01)

Clinical manifestations and prognostic factors analysis of patients hospitalised with acute exacerbation of idiopathic pulmonary fibrosis and other interstitial lung diseases
by: Huijuan Wang, et al.
Published: (2024-02-01)

Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be
by: Tinne Goos, et al.
Published: (2021-03-01)

The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population.
by: Raphael Borie, et al.
Published: (2013-01-01)

Reliability and validity of Chinese version of a tool to assess the quality of life in idiopathic pulmonary fibrosis in patients with interstitial lung disease
by: Rui-Li Pan, et al.
Published: (2019-01-01)

Limitations to the 6-Minute Walk Test in Dermatomyositis with Interstitial Lung Disease in Comparison with Idiopathic Interstitial Pneumonia
by: Fujiko Someya, et al.
Published: (2013-01-01)